FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103708377> ?p ?o ?g. }

• W2103708377 endingPage "1893" @default.
• W2103708377 startingPage "1886" @default.
• W2103708377 abstract "Purpose To evaluate the efficacy of recombinant erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) in reducing blood transfusion requirements and stimulating hematopoiesis in children with high-risk neuroblastoma. Patients and Methods Thirty-eight patients given six cycles of intensive induction chemotherapy for high-risk neuroblastoma were randomized to receive G-CSF (n = 20) or G-CSF + EPO (n = 18). Cytokines were given subcutaneously each day, starting 24 hours after each chemotherapy cycle and continuing until 48 hours before the start of the next cycle. The primary end point was the effect of EPO on total red cell transfusion requirements during induction therapy. Results Patients who received G-CSF + EPO had a higher red cell transfusion requirement (median, 161.0 mL/kg) than did those who received G-CSF alone (median, 106.6 mL/kg; P = .005). In addition, among patients given transfusions for hemoglobin ≤ 8 g/dL, those in the G-CSF + EPO group received more red cell transfusions than did those given G-CSF alone (median per patient, 10 v 8, respectively; P = .044). The two treatment groups had similar cumulative durations of neutropenia, incidences of febrile neutropenia, platelet transfusion requirements, and numbers of platelet transfusions; they also received induction chemotherapy for similar durations and had similar probabilities of progression-free survival and overall survival. Conclusion The addition of EPO to the G-CSF regimen provides no benefit for patients receiving intensive induction chemotherapy for high-risk neuroblastoma." @default.
• W2103708377 created "2016-06-24" @default.
• W2103708377 creator A5012423746 @default.
• W2103708377 creator A5032946348 @default.
• W2103708377 creator A5034374604 @default.
• W2103708377 creator A5048193615 @default.
• W2103708377 creator A5058782198 @default.
• W2103708377 date "2004-05-15" @default.
• W2103708377 modified "2023-09-23" @default.
• W2103708377 title "Combined Use of Erythropoietin and Granulocyte Colony-Stimulating Factor Does Not Decrease Blood Transfusion Requirements During Induction Therapy for High-Risk Neuroblastoma: A Randomized Controlled Trial" @default.
• W2103708377 cites W1587578749 @default.
• W2103708377 cites W1957959321 @default.
• W2103708377 cites W1963914887 @default.
• W2103708377 cites W1964396258 @default.
• W2103708377 cites W1970997581 @default.
• W2103708377 cites W1974954809 @default.
• W2103708377 cites W1975174081 @default.
• W2103708377 cites W1979652151 @default.
• W2103708377 cites W1997526422 @default.
• W2103708377 cites W1999956995 @default.
• W2103708377 cites W2010742291 @default.
• W2103708377 cites W2017855179 @default.
• W2103708377 cites W2025122282 @default.
• W2103708377 cites W2045772872 @default.
• W2103708377 cites W2079895822 @default.
• W2103708377 cites W2088504665 @default.
• W2103708377 cites W2099907884 @default.
• W2103708377 cites W2101033273 @default.
• W2103708377 cites W2110949925 @default.
• W2103708377 cites W2142920892 @default.
• W2103708377 cites W2150368387 @default.
• W2103708377 cites W2159283488 @default.
• W2103708377 cites W2257281028 @default.
• W2103708377 cites W2257461724 @default.
• W2103708377 cites W2262641481 @default.
• W2103708377 cites W2317690033 @default.
• W2103708377 cites W2327522594 @default.
• W2103708377 cites W2413955902 @default.
• W2103708377 cites W2418112081 @default.
• W2103708377 cites W3140909591 @default.
• W2103708377 cites W35258240 @default.
• W2103708377 cites W4242329867 @default.
• W2103708377 cites W4243040283 @default.
• W2103708377 cites W4255803928 @default.
• W2103708377 cites W53850359 @default.
• W2103708377 doi "https://doi.org/10.1200/jco.2004.01.002" @default.
• W2103708377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15143081" @default.
• W2103708377 hasPublicationYear "2004" @default.
• W2103708377 type Work @default.
• W2103708377 sameAs 2103708377 @default.
• W2103708377 citedByCount "26" @default.
• W2103708377 countsByYear W21037083772012 @default.
• W2103708377 countsByYear W21037083772013 @default.
• W2103708377 countsByYear W21037083772014 @default.
• W2103708377 countsByYear W21037083772015 @default.
• W2103708377 countsByYear W21037083772016 @default.
• W2103708377 countsByYear W21037083772017 @default.
• W2103708377 countsByYear W21037083772020 @default.
• W2103708377 countsByYear W21037083772021 @default.
• W2103708377 crossrefType "journal-article" @default.
• W2103708377 hasAuthorship W2103708377A5012423746 @default.
• W2103708377 hasAuthorship W2103708377A5032946348 @default.
• W2103708377 hasAuthorship W2103708377A5034374604 @default.
• W2103708377 hasAuthorship W2103708377A5048193615 @default.
• W2103708377 hasAuthorship W2103708377A5058782198 @default.
• W2103708377 hasConcept C126322002 @default.
• W2103708377 hasConcept C141071460 @default.
• W2103708377 hasConcept C2776689292 @default.
• W2103708377 hasConcept C2776694085 @default.
• W2103708377 hasConcept C2776715637 @default.
• W2103708377 hasConcept C2777063308 @default.
• W2103708377 hasConcept C2777767877 @default.
• W2103708377 hasConcept C2778534260 @default.
• W2103708377 hasConcept C2778850193 @default.
• W2103708377 hasConcept C2781413609 @default.
• W2103708377 hasConcept C54355233 @default.
• W2103708377 hasConcept C71924100 @default.
• W2103708377 hasConcept C81885089 @default.
• W2103708377 hasConcept C86803240 @default.
• W2103708377 hasConcept C89560881 @default.
• W2103708377 hasConcept C90924648 @default.
• W2103708377 hasConceptScore W2103708377C126322002 @default.
• W2103708377 hasConceptScore W2103708377C141071460 @default.
• W2103708377 hasConceptScore W2103708377C2776689292 @default.
• W2103708377 hasConceptScore W2103708377C2776694085 @default.
• W2103708377 hasConceptScore W2103708377C2776715637 @default.
• W2103708377 hasConceptScore W2103708377C2777063308 @default.
• W2103708377 hasConceptScore W2103708377C2777767877 @default.
• W2103708377 hasConceptScore W2103708377C2778534260 @default.
• W2103708377 hasConceptScore W2103708377C2778850193 @default.
• W2103708377 hasConceptScore W2103708377C2781413609 @default.
• W2103708377 hasConceptScore W2103708377C54355233 @default.
• W2103708377 hasConceptScore W2103708377C71924100 @default.
• W2103708377 hasConceptScore W2103708377C81885089 @default.
• W2103708377 hasConceptScore W2103708377C86803240 @default.
• W2103708377 hasConceptScore W2103708377C89560881 @default.
• W2103708377 hasConceptScore W2103708377C90924648 @default.
• W2103708377 hasIssue "10" @default.

• next